Literature DB >> 8203823

Fluorescent in situ hybridization as an adjunct to conventional cytogenetics.

H F Mark1.   

Abstract

Fluorescent in situ hybridization (FISH) is a molecular cytogenetic technique that exploits the availability of recombinant deoxyribonucleic acid (DNA) technology. In metaphase FISH, a specific nucleic acid sequence (probe) is bound to the homologous segment on a metaphase chromosome in a fixed preparation on a glass slide. The presence of a region-specific DNA sequence in a nondividing cell can be detected using interphase FISH. Interphase cytogenetics via FISH can be performed on fixed cells harvested during a routine culture, on tissue sections and on many cytologic specimens. Specific examples of clinical and research applications are discussed to illustrate the utility of FISH in the detection of constitutional and acquired chromosomal abnormalities.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8203823

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  4 in total

1.  2E4/Kaptin (KPTN)--a candidate gene for the hearing loss locus, DFNA4.

Authors:  E L Bearer; A F Chen; A H Chen; Z Li; H F Mark; R J Smith; C L Jackson
Journal:  Ann Hum Genet       Date:  2000-05       Impact factor: 1.670

2.  Proposal of a scoring scale as a survival predictor in intracranial oligodendrogliomas.

Authors:  Abderrahmane Hamlat; Stephan Saikali; Jacques Chaperon; Beatrice Carsin-Nicol; Michéle Le Calve; Thierry Lesimple; Mohamed Ben-hassel; Yvon Guegan
Journal:  J Neurooncol       Date:  2006-09       Impact factor: 4.130

3.  Fluorescent in situ hybridization in routinely processed bone marrow aspirate clot and core biopsy sections.

Authors:  R N Miranda; H F Mark; L J Medeiros
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

4.  Fluorescent in situ hybridization assessment of chromosome 8 copy number in breast cancer.

Authors:  A Afify; K I Bland; H F Mark
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.